S-Alpha Therapeutics Stock

S-Alpha Therapeutics engages in the research and development of health apps and digital therapeutics.

Sign up today and learn more about S-Alpha Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About S-Alpha Therapeutics Stock

S-Alpha Therapeutics develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology. Company has developed several digital therapeutic products in its R&D pipeline.

Funding History

April 2020$500M
December 2020$3.0B
August 2021$10.0B
March 2023$11.0B


Chief Strategy Officer

Yongsun Lee

Co-Founder & CEO

SeungEun Choi

Chief Medical Officer & Co-Founder

Myung Joon Kim


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: